Vortioxetine's impact on the autonomic nervous system in depressed children and adolescents: analysis of the heart rate variability.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 06 2024
Historique:
received: 30 01 2024
accepted: 18 06 2024
medline: 24 6 2024
pubmed: 24 6 2024
entrez: 23 6 2024
Statut: epublish

Résumé

Relationship between depressive disorder and autonomic nervous system has been already discussed. Reduced emotional regulation is supposed to be associated with prefrontal hypofunction and subcortical hyperactivity. The aim of this study was to determine the effect of vortioxetine on heart rate variability (HRV), a parameter of cardiac autonomic regulation, in depressed hospitalized paediatric patients and assess the clinical effectiveness of the drug in this population. We performed repeated polysomnography analyses at admission and after a short treatment in hospital (15.2 days on average) and measured various HRV parameters (RRi, pNN50, RMSSD, LF-HRV, HF-HRV) during wakefulness, N3 and REM sleep stages. Out of 27 study subjects, 67% have improved depression symptoms as well as anxiety and subjective sleep quality after short vortioxetine treatment. We have found a significant decrease in parasympathetic parameters pNN50, RMSSD and HF-HRV during N3 sleep phase, though not exclusively among vortioxetine responders. The anticipated increase in cardiovagal regulation after vortioxetine treatment was not demonstrated in this pilot study, possibly due to the drug's multimodal mechanism and impact on the nucleus tractus solitarii, particularly its antagonism on 5HT-3 receptors. Application of selective drugs could further explain the effect of vortioxetine on HRV in depressed patients.

Identifiants

pubmed: 38910177
doi: 10.1038/s41598-024-65278-9
pii: 10.1038/s41598-024-65278-9
doi:

Substances chimiques

Vortioxetine 3O2K1S3WQV
Antidepressive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14442

Subventions

Organisme : Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic
ID : VEGA 1/0048/24

Informations de copyright

© 2024. The Author(s).

Références

Berry, D., Palmer, A. R., Distefano, R. & Masten, A. S. Autonomic complexity and emotion (dys-)regulation in early childhood across high- and low-risk contexts. Dev. Psychopathol. 31(3), 1173–1190. https://doi.org/10.1017/S0954579419000683 (2019).
doi: 10.1017/S0954579419000683 pubmed: 31290736 pmcid: 6790229
WHO, ‘Mental health of adolescents’. Accessed 24 Oct 2023. https://www.who.int/news-room/fact-sheets/detail/adolescent-mental-health (2023).
Porges, S. W. Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A Polyvagal theory. Psychophysiology 32(4), 301–318. https://doi.org/10.1111/j.1469-8986.1995.tb01213.x (1995).
doi: 10.1111/j.1469-8986.1995.tb01213.x pubmed: 7652107
Porges, S. W. The polyvagal perspective. Biol. Psychol. 74(2), 116–143. https://doi.org/10.1016/j.biopsycho.2006.06.009 (2007).
doi: 10.1016/j.biopsycho.2006.06.009 pubmed: 17049418
Thayer, J. F. & Lane, R. D. A model of neurovisceral integration in emotion regulation and dysregulation. J. Affect. Disord. 61(3), 201–216. https://doi.org/10.1016/S0165-0327(00)00338-4 (2000).
doi: 10.1016/S0165-0327(00)00338-4 pubmed: 11163422
Benarroch, E. E. The central autonomic network: Functional organization, dysfunction, and perspective. Mayo Clin. Proc. 68(10), 988–1001. https://doi.org/10.1016/s0025-6196(12)62272-1 (1993).
doi: 10.1016/s0025-6196(12)62272-1 pubmed: 8412366
Yang, T. T. et al. Increased Amygdala activation is related to heart rate during emotion processing in adolescent subjects. Neurosci. Lett. 428(2–3), 109–114. https://doi.org/10.1016/j.neulet.2007.09.039 (2007).
doi: 10.1016/j.neulet.2007.09.039 pubmed: 18029095 pmcid: 2171034
Hänsel, A. & von Känel, R. The ventro-medial prefrontal cortex: A major link between the autonomic nervous system, regulation of emotion, and stress reactivity?. Biopsychosoc. Med. 2, 21. https://doi.org/10.1186/1751-0759-2-21 (2008).
doi: 10.1186/1751-0759-2-21 pubmed: 18986513 pmcid: 2590602
Thayer, J. F. & Lane, R. D. Claude Bernard and the heart–brain connection: Further elaboration of a model of neurovisceral integration. Neurosci. Biobehav. Rev. 33(2), 81–88. https://doi.org/10.1016/j.neubiorev.2008.08.004 (2009).
doi: 10.1016/j.neubiorev.2008.08.004 pubmed: 18771686
Bujnakova, I. et al. Autism spectrum disorder is associated with autonomic underarousal. Physiol. Res. 65(Suppl 5), S673–S682. https://doi.org/10.33549/physiolres.933528 (2016).
doi: 10.33549/physiolres.933528 pubmed: 28006949
Tonhajzerova, I. et al. Cardiac autonomic regulation is impaired in girls with major depression. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 34(4), 613–618. https://doi.org/10.1016/j.pnpbp.2010.02.023 (2010).
doi: 10.1016/j.pnpbp.2010.02.023
Musser, E. D. et al. Emotion regulation via the autonomic nervous system in children with attention-deficit/hyperactivity disorder (ADHD). J. Abnorm. Child. Psychol. 39(6), 841–852. https://doi.org/10.1007/s10802-011-9499-1 (2011).
doi: 10.1007/s10802-011-9499-1 pubmed: 21394506 pmcid: 3112468
Weise, S. et al. Emotion dysregulation and resting-state autonomic function in adolescent borderline personality disorder-A multimodal assessment approach. Personal. Disord. 11(1), 46–53. https://doi.org/10.1037/per0000367 (2020).
doi: 10.1037/per0000367 pubmed: 31670544
Koch, C., Wilhelm, M., Salzmann, S., Rief, W. & Euteneuer, F. A meta-analysis of heart rate variability in major depression. Psychol. Med. 49(12), 1948–1957. https://doi.org/10.1017/S0033291719001351 (2019).
doi: 10.1017/S0033291719001351 pubmed: 31239003
Kemp, A. H. et al. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biol. Psychiatry 67(11), 1067–1074. https://doi.org/10.1016/j.biopsych.2009.12.012 (2010).
doi: 10.1016/j.biopsych.2009.12.012 pubmed: 20138254
van Zyl, L. T., Hasegawa, T. & Nagata, K. Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. BioPsychoSocial Med. 2(1), 12. https://doi.org/10.1186/1751-0759-2-12 (2008).
doi: 10.1186/1751-0759-2-12
Chen, S., Wang, H., Yue, J., Guan, N. & Wang, X. Intervention methods for improving reduced heart rate variability in patients with major depressive disorder: A systematic review and meta-analysis. Compr. Psychiatry 119, 152347. https://doi.org/10.1016/j.comppsych.2022.152347 (2022).
doi: 10.1016/j.comppsych.2022.152347 pubmed: 36183449
Koenig, J. et al. Increases in orbitofrontal cortex thickness following antidepressant treatment are associated with changes in resting state autonomic function in adolescents with major depression—Preliminary findings from a pilot study. Psychiatry Res. Neuroimaging 281, 35–42. https://doi.org/10.1016/j.pscychresns.2018.08.013 (2018).
doi: 10.1016/j.pscychresns.2018.08.013 pubmed: 30216863 pmcid: 6204080
Choi, K. W. & Jeon, H. J. Heart rate variability for the prediction of treatment response in major depressive disorder. Front. Psychiatry https://doi.org/10.3389/fpsyt.2020.00607 (2020).
doi: 10.3389/fpsyt.2020.00607 pubmed: 33551861 pmcid: 7725748
D’Agostino, A., English, C. D. & Rey, J. A. Vortioxetine (Brintellix): A new serotonergic antidepressant. P T 40(1), 36–40 (2015).
pubmed: 25628505 pmcid: 4296590
Findling, R. L. et al. Pharmacokinetics and safety of vortioxetine in pediatric patients. J. Child Adolesc. Psychopharmacol. 27(6), 526–534. https://doi.org/10.1089/cap.2016.0155 (2017).
doi: 10.1089/cap.2016.0155 pubmed: 28333546 pmcid: 5568018
Findling, R. L. et al. A 6-month open-label extension study of vortioxetine in pediatric patients with depressive or anxiety disorders. J. Child Adolesc. Psychopharmacol. 28(1), 47–54. https://doi.org/10.1089/cap.2017.0047 (2018).
doi: 10.1089/cap.2017.0047 pubmed: 29035574 pmcid: 5771527
Findling, R. L. et al. Vortioxetine for major depressive disorder in adolescents: 12-week randomized, placebo-controlled, fluoxetine-referenced, fixed-dose study. J. Am. Acad. Child Adolesc. Psychiatry 61(9), 1106-1118.e2. https://doi.org/10.1016/j.jaac.2022.01.004 (2022).
doi: 10.1016/j.jaac.2022.01.004 pubmed: 35033635
de Vries, H., Oldenhuis, H., van der Schans, C., Sanderman, R. & Kamphuis, W. Does wearable-measured heart rate variability during sleep predict perceived morning mental and physical fitness?. Appl. Psychophysiol. Biofeedback 48(2), 247–257. https://doi.org/10.1007/s10484-022-09578-8 (2023).
doi: 10.1007/s10484-022-09578-8 pubmed: 36622531 pmcid: 10195711
Vanoli, E. et al. Heart rate variability during specific sleep stages. Circulation 91(7), 1918–1922. https://doi.org/10.1161/01.CIR.91.7.1918 (1995).
doi: 10.1161/01.CIR.91.7.1918 pubmed: 7895347
Du, Y. et al. Vortioxetine improves rapid eye movement sleep behavior disorder: A case report. Medicine (Baltimore) 99(26), e21003. https://doi.org/10.1097/MD.0000000000021003 (2020).
doi: 10.1097/MD.0000000000021003 pubmed: 32590816
Mlyncekova, Z. et al. Vortioxetine effects on sleep architecture in treatment of comorbid depression in adolescent patient with Narcolepsy and cataplexy: Case report. Neuro Endocrinol. Lett. 42(8), 503–507 (2021).
pubmed: 34969190
Mahableshwarkar, A. R., Jacobsen, P. L., Chen, Y. & Simon, J. S. A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder. Int. J. Clin. Pract. 68(1), 49–59. https://doi.org/10.1111/ijcp.12328 (2014).
doi: 10.1111/ijcp.12328 pubmed: 24341301
Licht, C. M. M., de Geus, E. J. C., van Dyck, R. & Penninx, B. W. J. H. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol. Psychiatry 68(9), 861–868. https://doi.org/10.1016/j.biopsych.2010.06.032 (2010).
doi: 10.1016/j.biopsych.2010.06.032 pubmed: 20843507
Mezzacappa, E., Steingard, R., Kindlon, D., Philip Saul, J. & Earls, F. Tricyclic antidepressants and cardiac autonomic control in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry 37(1), 52–59. https://doi.org/10.1097/00004583-199801000-00017 (1998).
doi: 10.1097/00004583-199801000-00017 pubmed: 9444900
Srinivasan, K., Ashok, M. V., Vaz, M. & Yeragani, V. K. Effect of imipramine on linear and nonlinear measures of heart rate variability in children. Pediatr. Cardiol. 25(1), 20–25. https://doi.org/10.1007/s00246-003-0468-5 (2004).
doi: 10.1007/s00246-003-0468-5 pubmed: 14598002
Vloet, T. D. et al. Mean heart rate and parameters of heart rate variability in depressive children and the effects of antidepressant medication. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 47(3), 253–260. https://doi.org/10.1024/1422-4917/a000672 (2019).
doi: 10.1024/1422-4917/a000672 pubmed: 30971175
Koenig, J., Kemp, A. H., Beauchaine, T. P., Thayer, J. F. & Kaess, M. Depression and resting state heart rate variability in children and adolescents—a systematic review and meta-analysis. Clin. Psychol. Rev. 46, 136–150. https://doi.org/10.1016/j.cpr.2016.04.013 (2016).
doi: 10.1016/j.cpr.2016.04.013 pubmed: 27185312
Herzig, D. et al. Reproducibility of heart rate variability is parameter and sleep stage dependent. Front. Physiol. 8, 1100. https://doi.org/10.3389/fphys.2017.01100 (2017).
doi: 10.3389/fphys.2017.01100 pubmed: 29367845
Chouchou, F. & Desseilles, M. Heart rate variability: A tool to explore the sleeping brain?. Front. Neurosci. 8, 402. https://doi.org/10.3389/fnins.2014.00402 (2014).
doi: 10.3389/fnins.2014.00402 pubmed: 25565936 pmcid: 4263095
Ramage, A. G. & Villalón, C. M. 5-Hydroxytryptamine and cardiovascular regulation. Trends Pharmacol. Sci. 29(9), 472–481. https://doi.org/10.1016/j.tips.2008.06.009 (2008).
doi: 10.1016/j.tips.2008.06.009 pubmed: 19086344
Baumeister-Lingens, L. et al. Vagally-mediated heart rate variability and depression in children and adolescents—A meta-analytic update. J. Affect. Disord. 339, 237–255. https://doi.org/10.1016/j.jad.2023.07.027 (2023).
doi: 10.1016/j.jad.2023.07.027 pubmed: 37437729
APA, (ed.) Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th edn, (American Psychiatric Association, 2013).
Montgomery, S. A. & Asberg, M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382–389. https://doi.org/10.1192/bjp.134.4.382 (1979).
doi: 10.1192/bjp.134.4.382 pubmed: 444788
Quilty, L. C. et al. The structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression. Int. J. Methods Psychiatr. Res. 22(3), 175–184. https://doi.org/10.1002/mpr.1388 (2013).
doi: 10.1002/mpr.1388 pubmed: 24038301 pmcid: 6878407
Shailesh, J. et al. Psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children. J. Am. Acad. Child Adolesc. Psychiatry 46(9), 1201–1212 (2007).
Kovacs, M. & Beck, A. An empirical-clinical approach toward a definition of childhood depression. In Depression in Childhood Diagnosis, Treatment and Conceptual Models (eds Schulterbrandt, J. G. & Raskin, A.) 1–25 (Raven Press, New York, 1977).
Matthey, S. & Petroversuski, P. The children’s depression inventory: Error in cutoff scores for screening purposes. Psychol. Assess. 14(2), 146–149. https://doi.org/10.1037/1040-3590.14.2.146 (2002).
doi: 10.1037/1040-3590.14.2.146 pubmed: 12056076
Thompson, E. Hamilton rating scale for anxiety (HAM-A). Occup. Med. 65(7), 601. https://doi.org/10.1093/occmed/kqv054 (2015).
doi: 10.1093/occmed/kqv054
Clark, D. B. & Donovan, J. E. Reliability and validity of the hamilton anxiety rating scale in an adolescent sample. J. Am. Acad. Child Adolesc. Psychiatry 33(3), 354–360. https://doi.org/10.1097/00004583-199403000-00009 (1994).
doi: 10.1097/00004583-199403000-00009 pubmed: 8169180
Soldatos, C. R., Dikeos, D. G. & Paparrigopoulos, T. J. The diagnostic validity of the athens insomnia scale. J. Psychosom. Res. 55(3), 263–267. https://doi.org/10.1016/s0022-3999(02)00604-9 (2003).
doi: 10.1016/s0022-3999(02)00604-9 pubmed: 12932801
Chung, K. F., Kan, K. K. K. & Yeung, W. F. Assessing insomnia in adolescents: Comparison of insomnia severity index, athens insomnia scale and sleep quality index. Sleep Med. 12(5), 463–470. https://doi.org/10.1016/j.sleep.2010.09.019 (2011).
doi: 10.1016/j.sleep.2010.09.019 pubmed: 21493134
Pandi-Perumal, S. R., Spence, D. W. & BaHammam, A. S. Polysomnography: An overview. In Primary Care Sleep Medicine: A Practical Guide (eds Pagel, J. F. & Pandi-Perumal, S. R.) 29–42 (Springer, New York, 2014).
doi: 10.1007/978-1-4939-1185-1_4
Berry, R. B. et al. AASM scoring manual updates for 2017 (Version 2.4). J. Clin. Sleep Med. 13(5), 665–666. https://doi.org/10.5664/jcsm.6576 (2017).
doi: 10.5664/jcsm.6576 pubmed: 28416048 pmcid: 5406946
Tarvainen, M. P., Ranta-Aho, P. O. & Karjalainen, P. A. An advanced detrending method with application to HRV analysis. IEEE Trans. Biomed. Eng. 49(2), 172–175. https://doi.org/10.1109/10.979357 (2002).
doi: 10.1109/10.979357 pubmed: 12066885
Shaffer, F. & Ginsberg, J. P. An overview of heart rate variability metrics and norms. Front. Public. Health 5, 258. https://doi.org/10.3389/fpubh.2017.00258 (2017).
doi: 10.3389/fpubh.2017.00258 pubmed: 29034226 pmcid: 5624990
Malik, M. et al. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Eur. Heart J. 17(3), 354–381. https://doi.org/10.1093/oxfordjournals.eurheartj.a014868 (1996).
doi: 10.1093/oxfordjournals.eurheartj.a014868
Kleiger, R. E., Stein, P. K., Bosner, M. S. & Rottman, J. N. Time domain measurements of heart rate variability. Cardiol. Clin. 10(3), 487–498 (1992).
doi: 10.1016/S0733-8651(18)30230-3 pubmed: 1504980

Auteurs

Michaela Krivosova (M)

Jessenius Faculty of Medicine in Martin, Biomedical Centre Martin, Comenius University Bratislava, Martin, Slovakia.

Peter Hutka (P)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Igor Ondrejka (I)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia. igor.ondrejka@uniba.sk.

Zuzana Visnovcova (Z)

Jessenius Faculty of Medicine in Martin, Biomedical Centre Martin, Comenius University Bratislava, Martin, Slovakia.

Dana Funakova (D)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Igor Hrtanek (I)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Nikola Ferencova (N)

Jessenius Faculty of Medicine in Martin, Biomedical Centre Martin, Comenius University Bratislava, Martin, Slovakia.

Zuzana Mlyncekova (Z)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Veronika Kovacova (V)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Andrea Macejova (A)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Tomas Kukucka (T)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.

Juraj Mokry (J)

Department of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia.

Ingrid Tonhajzerova (I)

Jessenius Faculty of Medicine in Martin, Psychiatric Clinic, Comenius University Bratislava, University Hospital Martin, Martin, Slovakia.
Department of Physiology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, Martin, Slovakia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH